Mostly Cloudy 47°
Tag:

Global pandemic

News
COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus
Covid-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus A new pharmaceutical company is throwing its hat in the ring as the country continues its fight against COVID-19. Merck and Ridgeback Biotherapeutics announced on Friday, Oct. 1 that it is planning to apply for federal emergency approval of a pill that can reportedly help prevent hospitalizations and deaths in COVID-19 patients. According to the company, trials have found that the pill - dubbed molnupiravir - could potentially reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 by approximately 50 percent. The results of the late-stage trial have bee…

SHARE

by Zak Failla
News
COVID-19: NY Could Begin Administering Vaccine To Children 12 To 15 This Week COVID-19: NY Could Begin Administering Vaccine To Children 12 To 15 This Week
Covid-19: NY Could Begin Administering Vaccine To Children 12 To 15 This Week Children in New York between the ages of 12 and 15 may soon become the latest group eligible to receive the COVID-19 vaccine if their parents give their approval. Gov. Andrew Cuomo said that the Pfizer double-dose vaccine could be authorized for use among children in New York as soon as Thursday, May 13 if the state health commissioner and his Clinical Advisory Task Force recommend it. Cuomo said that if the Centers for Disease Control and Prevention (CDC) gives the green light following a scheduled meeting on Wednesday, May 12, as expected, it will go to the state’s advisory board, simila…

SHARE

by Zak Failla
News
COVID-19: Here's Long Island Three-Day Testing Trend, Number Of New Cases In Each County COVID-19: Here's Long Island Three-Day Testing Trend, Number Of New Cases In Each County
Covid-19: Here's Long Island Three-Day Testing Trend, Number Of New Cases In Each County The number of positive test results for COVID-19 has remained steady on Long Island, according to three-day data released Sunday, Oct. 11. In "Red Zone" focus areas included as part of the New York State's Cluster Action Initiative, the positivity rate for test results reported on Saturday, Oct. 10 was 5.74 percent and 6.13 percent for the past week.  These "Red Zone" focus areas are home to 2.8 percent of New York's population, yet have had 17.6 percent of all positive cases reported the last week statewide. New York State's positivity rate without the Red Zone focus areas…

SHARE

by Joe Lombardi